Yin Yuan

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

The efficacy of Shenyankangfu tablets in combination with valsartan in diabetic nephropathy: A systematic review and meta-analysis.

The efficacy of Shenyankangfu tablets in combination with valsartan in diabetic nephropathy: A systematic review and meta-analysis.

Journal: Medicine

Published: February 28, 2025

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer.

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer.

Journal: Frontiers in chemistry

Published: December 17, 2021

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer.

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer.

Journal: Journal of Cancer

Published: November 18, 2020

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.

Journal: BMC cancer

Published: July 14, 2020

Effect of Apatinib on Invasion and Migration of Lung Cancer Cells and Its Mechanism

Effect of Apatinib on Invasion and Migration of Lung Cancer Cells and Its Mechanism

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 22, 2019

Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database

Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 22, 2019

Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells

Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 22, 2019

Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer.

Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer.

Journal: OncoTargets and therapy

Published: May 20, 2019

Expression and Clinical Significance of LC-3 and P62  in Non-small Cell Lung Cancer

Expression and Clinical Significance of LC-3 and P62  in Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: June 28, 2018

Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells

Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 17, 2018

HOTAIR lncRNA SNPs rs920778 and rs1899663 are associated with smoking, male gender, and squamous cell carcinoma in a Chinese lung cancer population.

HOTAIR lncRNA SNPs rs920778 and rs1899663 are associated with smoking, male gender, and squamous cell carcinoma in a Chinese lung cancer population.

Journal: Acta pharmacologica Sinica

Published: February 13, 2018

miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.

miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 30, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026